Şunu aradınız:: apibdinimas (Litvanca - İngilizce)

klinikinis apibdinimas
· clinical description

daznio apibdinimas:
frequencies are defined as follows:

a) bendras apibdinimas
a) general description

metabolinis tipranaviro apibdinimas.
metabolic profile of tipranavir:

veikliosios medziagos () apibdinimas
statement of active substance(s)

qi09aa06. be trumpas veiklij medziag apibdinimas.
qi09aa06

vidutinis amzius (metai) ligos apibdinimas (%)
median age (years) disease characteristics (%) rai stage iii/iv b symptoms prior therapies (%):

salutinio poveikio sutrikim daznio apibdinimas pateiktas toliau.
the frequency of side effects is classified into the following categories: in more than 1 in 10 patients very common

toje pacioje lentelje papildomai pateikiamas ir vlesnis (post-hoc) atsako apibdinimas.
in addition, a post-hoc definition of response is provided in the same table.

bendras farmakokinetikos apibdinimas buvo tirta vorikonazolo farmakokinetika sveik savanori, speciali zmoni grupi ir ligoni organizme.
general pharmacokinetic characteristics the pharmacokinetics of voriconazole have been characterised in healthy subjects, special populations and patients.

daznio apibdinimai labai dazni (1/10) dazni (nuo 1/100 iki 1/10) nedazni (nuo 1/1 000 iki 1/100) reti (nuo 1/10 000 iki 1/1 000) labai reti ( 1/10 000) , daznis nezinomas (negali bti vertintas pagal turimus duomenis)
assessment of frequencies:very common (1/10) common (1/100 to 1/10) uncommon (1/1,000 to 1/100) rare (1/10,000 to 1/1,000) very rare ( 1/10,000) , not known (cannot be estimated from the available data)